{
    "Trade/Device Name(s)": [
        "Alinity c Glucose Reagent Kit",
        "Alinity c System"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K170316",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060383",
        "K980367"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFR",
        "JJE"
    ],
    "Summary Letter Date": "September 06, 2017",
    "Summary Letter Received Date": "September 07, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator tube",
        "EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube",
        "Sodium fluoride/potassium oxalate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Alinity c analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Hexokinase",
        "G-6-PDH",
        "Photometric detection"
    ],
    "Methodologies": [
        "End-point colorimetric",
        "Enzymatic"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "Reagent",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for Alinity c Glucose Reagent Kit and Alinity c System for quantitative measurement of glucose in serum, plasma, urine, and CSF using automated chemistry analyzer",
    "Indications for Use Summary": "Quantitative measurement of glucose in human serum, plasma, urine, or cerebrospinal fluid for diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, idiopathic hypoglycemia, and pancreatic islet cell carcinoma",
    "fda_folder": "Clinical Chemistry"
}